Adverse obstetric outcome in low- and high-risk pregnancies: Predictive value of maternal serum screening

Obstetrics and Gynecology

Volumn 94, Issue 6, 1999, Pages 929-934

  Van Rijn, M ^a,b   Van Der Schouw, Y T ^a,b   Hagenaars, A M ^a,b   Visser, G H A ^a,b   Christiaens, G C M L ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS DEATH; HIGH RISK PREGNANCY; HUMAN; LABOR COMPLICATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NEWBORN DEATH; PLACENTA PREVIA; PREDICTION; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; SCREENING; SOLUTIO PLACENTAE;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RISK ASSESSMENT;

EID: 0032745390     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00467-6     Document Type: Article

References (29)

1. Katz V.L., Chescheir N.C., Cefalo R.C. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv. 45:1990;719-726.
2. Thomas R.L., Blakemore K.J. Evaluation of elevations in maternal serum alpha-fetoprotein A review . Obstet Gynecol Surv. 45:1990;269-283.
3. Gravett C.P., Buckmaster J.G., Watson P.T., Gravett M.G. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet. 44:1992;485-486.
4. Gonen R., Perez R., David M., Dar H., Merksamer R., Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 80:1992;83-86.
5. Benn P.A., Horne D., Briganti S., Rodis J.F., Clive J.M. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol. 87:1996;217-222.
6. Morssink L.P., Kornman L.H., Beekhuis J.R., De Wolf B.T., Mantingh A. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester Relation to fetal weight and preterm delivery . Prenat Diagn. 15:1995;1041-1046.
7. Cusick W., Rodis J.F., Vintzileos A.M., Albini S.M., McMahon M., Campbell W.A. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. J Reprod Med. 41:1996;327-332.
8. Hurley T.J., Miller C., O'Brien T.J., Blacklaw M., Quirk J.G. Jr. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein. J Matern Fetal Med. 5:1996;340-344.
9. Vaillant P., David E., Constant I., Athmani B., Devulder G., Fievet P., et al. Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. Nephron. 72:1996;557-563.
10. Hsieh T.T., Hung T.H., Hsu J.J., Shau W.Y., Su C.W., Hsieh F.J. Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population. Obstet Gynecol. 89:1997;937-940.
11. Wenstrom K.D., Hauth J.C., Goldenberg R.L., DuBard M.B., Lea C. The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels. Am J Obstet Gynecol. 173:1995;1292-1296.
12. Davey D.A., MacGillivray I. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol. 158:1988;892-898.
13. Sibai B.M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) Much ado about nothing? Am J Obstet Gynecol. 162:1990;311-316.
14. Reynolds T.M., Penney M.D., Hughes H., John R. The effect of weight correction on risk calculations for Down's syndrome screening. Ann Clin Biochem. 28:1991;245-249.
15. Seppala M., Ruoslahti E. Alpha-fetoprotein in maternal serum A new marker for detection of fetal distress and intrauterine death . Am J Obstet Gynecol. 115:1973;48-52.
16. Garoff L., Seppala M. Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein. Am J Obstet Gynecol. 121:1975;257-261.
17. Rodeck C.H., Campbell S., Biswas S. Maternal plasma alpha-fetoprotein in normal and complicated pregnancies. Br J Obstet Gynaecol. 83:1976;24-32.
18. Waller D.K., Lustig L.S., Cunningham G.C., Feuchtbaum L.B., Hook E.B. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol. 88:1996;816-822.
19. Simpson J.L., Palomaki G.E., Mercer B., Haddow J.E., Andersen R., Sibai B., et al. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements. Am J Obstet Gynecol. 173:1995;1742-1748.
20. Haddow J.E., Knight G.J., Kloza E.M., Palomaki G.E. Alpha-fetoprotein, vaginal bleeding and pregnancy risk. Br J Obstet Gynaecol. 93:1986;589-593.
21. Brazerol W.F., Grover S., Donnenfeld A.E. Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol. 171:1994;1030-1035.
22. Tanaka M., Natori M., Kohno H., Ishimoto H., Kobayashi T., Nozawa S. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol. 81:1993;341-343.
23. Boyd P.A. Why might maternal serum AFP be high in pregnancies in which the fetus is normally formed? Br J Obstet Gynaecol. 99:1992;93-95.
24. Lieppman R.E., Williams M.A., Cheng E.Y., Resta R., Zingheim R., Hickok D.E., et al. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol. 168:1993;1852-1856.
25. Wenstrom K.D., Owen J., Boots L.R., DuBard M.B. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol. 171:1994;1038-1041.
26. Phillips O.P., Simpson J.L., Morgan C.D., Andersen R.N., Shulman L.P., Meyers C.M., et al. Unexplained elevated maternal serum alpha-fetoprotein is not predictive of adverse perinatal outcome in an indigent urban population. Am J Obstet Gynecol. 166:1992;978-982.
27. Waller D.K., Lustig L.S., Smith A.H., Hook E.B. Alpha-fetoprotein A biomarker for pregnancy outcome . Epidemiology. 4:1993;471-476.
28. Waller D.K., Lustig L.S., Cunningham G.C., Golbus M.S., Hook E.B. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med. 325:1991;6-10.
29. Wenstrom K.D., Owen J., Davis R.O., Brumfield C.G. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol. 87:1996;213-216.